ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) Stock Price & Overview

BIT:1ROG • CH0012032048

Current stock price

370 EUR
-4 (-1.07%)
Last:

The current stock price of 1ROG.MI is 370 EUR. Today 1ROG.MI is down by -1.07%. In the past month the price increased by 8.19%.

1ROG.MI Key Statistics

1-Month Range336 - 402
Current 1ROG.MI stock price positioned within its 1-month range.
Market Cap
299.423B
P/E
17.09
Fwd P/E
16.28
EPS (TTM)
21.65
Dividend Yield
3.05%

1ROG.MI Stock Performance

Today
-1.07%
1 Week
-9.31%
1 Month
+8.19%
3 Months
N/A
Longer-term
6 Months N/A
1 Year N/A
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

1ROG.MI Stock Chart

ROCHE HOLDING AG-GENUSSCHEIN / 1ROG Daily stock chart

1ROG.MI Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to 1ROG.MI.


Chartmill TA Rating
Chartmill Setup Rating

1ROG.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to 1ROG.MI. While 1ROG.MI belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

1ROG.MI Earnings

On January 29, 2026 1ROG.MI reported an EPS of 8.53 and a revenue of 30.57B. The company missed EPS expectations (-3.53% surprise) and missed revenue expectations (-3.25% surprise).

Next Earnings DateApr 23, 2026
Last Earnings DateJan 29, 2026
PeriodQ4 / 2025
EPS ReportedCHF8.53
Revenue Reported30.572B
EPS Surprise -3.53%
Revenue Surprise -3.25%

1ROG.MI Forecast & Estimates

For the next year, analysts expect an EPS growth of 5.01% and a revenue growth 1.49% for 1ROG.MI


Analysts
Analysts70.34
Price TargetN/A
EPS Next Y5.01%
Revenue Next Year1.49%

1ROG.MI Groups

Sector & Classification

Sub-Industry
Pharmaceuticals
Index Membership

1ROG.MI Financial Highlights

Over the last trailing twelve months 1ROG.MI reported a non-GAAP Earnings per Share(EPS) of 21.65. The EPS increased by 4.41% compared to the year before.


Income Statements
Revenue(TTM)61.52B
Net Income(TTM)12.88B
Industry RankSector Rank
PM (TTM) 20.94%
ROA 12.79%
ROE 38.1%
Debt/Equity 0.85
Chartmill High Growth Momentum
EPS Q2Q%-0.47%
Sales Q2Q%-0.24%
EPS 1Y (TTM)4.41%
Revenue 1Y (TTM)1.69%

1ROG.MI Ownership

Ownership
Inst Owners41.39%
Shares809.25M
Float688.92M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

About 1ROG.MI

Company Profile

1ROG logo image Roche Holding AG is a research healthcare company. The company is headquartered in Basel, Basel-Stadt and currently employs 112,774 full-time employees. The company went IPO on 2001-05-04. The firm's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The firm develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The firm offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Company Info

IPO: 2001-05-04

ROCHE HOLDING AG-GENUSSCHEIN

Grenzacherstrasse 124

Basel BASEL-STADT CH

Employees: 112774

1ROG Company Website

1ROG Investor Relations

Phone: 41616881111

ROCHE HOLDING AG-GENUSSCHEIN / 1ROG.MI FAQ

Can you describe the business of ROCHE HOLDING AG-GENUSSCHEIN?

Roche Holding AG is a research healthcare company. The company is headquartered in Basel, Basel-Stadt and currently employs 112,774 full-time employees. The company went IPO on 2001-05-04. The firm's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The firm develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The firm offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.


What is the current price of 1ROG stock?

The current stock price of 1ROG.MI is 370 EUR. The price decreased by -1.07% in the last trading session.


What is the dividend status of ROCHE HOLDING AG-GENUSSCHEIN?

ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) has a dividend yield of 3.05%. The yearly dividend amount is currently 11.66.


What is the ChartMill rating of ROCHE HOLDING AG-GENUSSCHEIN stock?

1ROG.MI has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


What is the Price/Earnings (PE) ratio of ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI)?

The PE ratio for ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) is 17.09. This is based on the reported non-GAAP earnings per share of 21.65 and the current share price of 370 EUR.


What is the market capitalization of 1ROG stock?

ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) has a market capitalization of 299.42B EUR. This makes 1ROG.MI a Mega Cap stock.


What is the ownership structure of ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI)?

You can find the ownership structure of ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) on the Ownership tab.